Goodwin Procter LLP advised Citigroup and other underwriters on the deal. Cooley LLP advised Opthea on the deal. Opthea Limited (ASX:OPT, Nasdaq: OPT), a clinical stage…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
